Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice.
Yi LiuDavid Quintanar GuerreroDavid Lechuga-BallesterosMingdian TanFaiz AhmadBilal AleiwiEdmund Lee EllsworthBin ChenMei-Sze ChuaSamuel SoPublished in: International journal of nanomedicine (2024)
We successfully developed an orally bioavailable formulation of niclosamide, which significantly enhanced oral bioavailability and anti-tumor efficacy in an HCC PDX mouse model. Our data support its clinical translation for the treatment of solid tumors.